Pozo-Rosich, Patricia
Poveda, José Luis
Crespo, Carlos
Martínez, María
Rodríguez, José Manuel
Irimia, Pablo
Funding for this research was provided by:
Novartis, Spain
Article History
Received: 24 November 2023
Accepted: 7 March 2024
First Online: 15 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: PP-R has earned fees from Novartis. JLP has earned fees from Novartis. PI has earned fees from Novartis. CC works in Axentiva Solutions, a consultancy firm that works for several pharmaceutical companies. MM and JMR work for Novartis España.